Heparin-induced thrombocytopenia (HIT)

Question

Is bleeding a common complication of heparin-induced thrombocytopenia?

Answer

Despite thrombocytopenia, bleeding is rather rare in HIT.

Question

What is the normal range for platelet counts in the blood, and what units are typically used to measure platelet count?

Answer

The normal range for platelet counts in the blood is 150000 to 400000 platelets per microliter, or 150 to 400 x 10^9 per Liter.

Question

Which direct thrombin inhibitor has a half-life of 39–51 min?

Answer

Argatroban has a half-life of 39–51 min.

Question

How long does it take for the platelet count to return to normal after discontinuing heparin treatment?

Answer

The platelet count usually starts to rise within 2-3 days after cessation of heparin treatment and returns to normal within 4-10 days. However, it takes another 2-3 months for antibodies to disappear.

Question

What are some other complications of heparin-induced thrombocytopenia?

Answer

Other complications of HIT include necrotizing skin lesions at the injection site in 10-20% of patients, and acute systemic reactions characterized by fever, chills, hypertension, tachycardia, chest pain, and dyspnea, in up to 25% of patients with circulating HIT antibodies.

Question

What is a Dalton?

Answer

A Dalton, also known as a unified atomic mass unit, is a non-SI unit of mass that is widely used in physics and chemistry. It is defined as 1⁄12 of the mass of an unbound neutral atom of carbon-12 in its nuclear and electronic ground state and at rest. This unit is commonly used to express the masses of atoms, molecules, and subatomic particles, such as protons, neutrons, and electrons. The use of Daltons allows for convenient and precise measurements of these masses, making it a valuable tool in various scientific fields.

Question

How is recombinant hirudin produced?

Answer

Recombinant hirudin was originally produced from the medicinal leech, but it can also be produced using recombinant DNA technology.

Question

What should be done if a patient has persistent or worsening thrombocytopenia despite stopping heparin treatment?

Answer

Other possible causes of thrombocytopenia should be considered and investigated. If the cause is found to be unrelated to heparin, a decision to recommence heparin should be made after careful risk-benefit analysis in individual patients.

Question

Have there been any anaphylactic deaths reported from argatroban administration?

Answer

No, no anaphylactic deaths have been reported from argatroban administration.

Question

What is the principal antigen responsible for the formation of antibodies in heparin-induced thrombocytopenia?

Answer

The principal antigen responsible for the formation of antibodies in HIT is a complex of heparin and platelet factor 4 (PF4), a small positively charged molecule, of uncertain biological function, that is normally found in the alpha granules of platelets. Heparin's high affinity for PF4 is dependent on its molecular weight, chain length, and degree of sulfation, which can vary between different types of heparins. This variability in heparin-PF4 interaction explains the differences in incidence of HIT observed with different heparins.

Question

What is recombinant hirudin?

Answer

Recombinant hirudin, also known as lepirudin, is a 65 amino acid peptide with a molecular weight of approximately 7000 Daltons. It is a direct, irreversible thrombin inhibitor that binds both free and clot-bound thrombin.

Question

What is Argatroban and how does it work?

Answer

Argatroban is a direct inhibitor of thrombin. It is an arginine-based synthetic anticoagulant that reversibly binds with the catalytic site of thrombin. This means that it can prevent blood clots from forming by inhibiting the action of thrombin.

Question

What type of complications are strongly associated with heparin-induced thrombocytopenia?

Answer

HIT is strongly associated with thromboembolic complications, which can be venous, arterial, or both. These complications include deep venous thrombosis, pulmonary embolism, myocardial infarction, thrombotic stroke, and occlusion of limb artery requiring amputation.

Question

In which patients should Lepirudin be used with caution and in a reduced dosage?

Answer

Lepirudin should be used with caution and in a reduced dosage in patients with serum creatinine values of greater than 1.6 mg per decilitre or 141.4 mmol per litre.

Question

What is the incidence of HIT among orthopaedic patients given subcutaneous prophylactic heparin, and how does it differ between unfractionated heparins and low molecular weight heparins?

Answer

Among orthopaedic patients given subcutaneous prophylactic heparin, the incidence of HIT is approximately 5% with unfractionated heparins and 0.5% with low molecular weight heparins.

Question

Which laboratory test is more sensitive and specific for detecting HIT antibodies?

Answer

The serotonin release assay (SRA) is the most sensitive and specific laboratory test for detecting HIT (Heparin-Induced Thrombocytopenia) antibodies. When washed platelets are used, the SRA has a sensitivity and specificity of 95%. However, it is more complex and technically demanding than other tests, and may not be readily available in most laboratories. The HIPA test, which is easier to perform, has a sensitivity of 35-85%. Immunoassays have high sensitivity but low specificity, and may detect antibodies that do not elicit HIT (false positives) and have decreased specificity in certain populations such as cardiac surgery patients. Testing becomes most effective when functional and immune assays are done in combination and multiple samples are taken.

Question

What are the different types of laboratory tests used to detect HIT antibodies?

Answer

There are two main types of laboratory tests used to detect HIT (Heparin-Induced Thrombocytopenia) antibodies: functional tests and immunoassays. Functional tests measure platelet activity in the presence of the patient's serum and heparin, and include heparin-induced platelet aggregation (HIPA), the serotonin release assay (SRA), and flow cytometric assays that detect platelet microparticle release. Immunoassays utilize immuno-enzymatic tests (ELISA) to detect the HIT antibody that binds to the PF4-heparin complex.

Question

Is Danaparoid in a high dose regimen equivalent to Lepirudin in the treatment of HIT with or without thrombosis?

Answer

Yes, Danaparoid in a high dose regimen is equivalent to Lepirudin in the treatment of HIT with or without thrombosis. The reduction in the incidence of the combined end point of death, new thromboembolic complications and limb amputation is comparable with Lepirudin.